Episode
Rethinking hair loss treatment
- Podcast
- BioSpace
- Published
- Jun 3, 2026
- Duration seconds
- 1305
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/rethinking-hair-loss-treatment/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/biospace-6696251/rethinking-hair-loss-treatment.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hair loss space, exploring why true innovation has lagged, how a regenerative approach aims to reactivate dormant follicles and what early proof-of-concept means for patients. Host Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Daniel Gil , CEO, Pelage Pharmaceuticals Francisco Ramírez-Valle , Senior Vice President, Immunology Discovery, Eli Lilly Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.